Obeticholic acid to prevent Barrett’s esophagus worsening
Part of Cancer, Digestive system clinical trials.
This Phase 2 trial tests whether obeticholic acid (a medicine) can help stop Barrett’s esophagus from getting worse. You must already be taking acid-suppressing medicine and have non-cancer Barrett’s changes, and the study checks safety and whether the lining improves or stays stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Barrett’s esophagus confirmed by biopsy, showing no dysplasia, indefinite dysplasia, or low-grade dysplasia
- Your biopsy/endoscopy must show Barrett’s tissue involvement of at least 2 cm, and at least one biopsy has 50% intestinal metaplasia
- You’ve been taking a proton pump inhibitor (PPI) for at least 28 days
- You’re 18 years or older, and you can sign consent and follow study instructions
- Your blood counts and organ tests (kidneys and liver) meet safety thresholds
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding the antifungal drug itraconazole to standard ablation therapy can help prevent esophageal cancer in people with high-risk Barrett's esophagus. You must have a confirmed diagnosis of Barrett's esophagus with low- or high-grade dysplasia or early-stage cancer, and be planning to have ablation treatment.
This study tests a new acid-reducing medicine (a potassium-competitive acid blocker) for people with Barrett's esophagus, a condition linked to acid reflux. It aims to see if this new treatment is safe and effective compared to standard proton pump inhibitors, and it might offer a better option for managing the condition.
This trial tests a new risk model to predict if early Barrett's esophagus-related cancer may return. It also looks at how telling patients their risk affects their quality of life and fear of cancer. If you have Barrett's with a small, early cancer, this study may help decide the best follow-up plan for you.
This trial tests two simple, non-surgical methods to look for Barrett's esophagus (a change in the lining of the swallowing tube) and early esophageal cancer. It is for people who are at higher risk or lower risk, but have never had Barrett's or cancer before.
This study tests minimally invasive, sample-based tests during an endoscopy to find Barrett’s esophagus and help sort it from esophageal cancer risk. It may help doctors spot changes earlier and more accurately using less invasive methods than standard tissue testing alone.
This study looks at how Barrett's esophagus affects your quality of life and fear of cancer. It uses new tests to better predict who might develop esophageal cancer, so you can get the right care sooner.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.